
Loading, please wait...

Loading, please wait...

The CONCEPTT trial randomized pregnant women with type 1 diabetes to real-time continuous glucose monitoring plus standard care or standard care alone. CGM use improved time spent in the target glucose range, reduced hyperglycemia, and was associated with better neonatal outcomes including lower rates of large-for-gestational-age birth and neonatal intensive care admission. For maternal-fetal medicine teams, the trial demonstrates that diabetes technology can be clinically meaningful in pregnancy when patients are trained to respond to trend information. The benefit is not simply the number of glucose readings but the ability to identify excursions and adjust insulin and nutrition in near real time. Implementation requires education, device access and rapid clinician feedback. The study supports a multidisciplinary model involving obstetrics, diabetology and diabetes educators, particularly for women at high risk of fetal overgrowth or glycemic instability.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The CONCEPTT trial randomized pregnant women with type 1 diabetes to real-time continuous glucose monitoring plus standard care or standard care alone. CGM use improved time spent in the target glucose range, reduced hyperglycemia, and was associated with better neonatal outcomes including lower rates of large-for-gestational-age birth and neonatal intensive care admission. For maternal-fetal medicine teams, the trial demonstrates that diabetes technology can be clinically meaningful in pregnancy when patients are trained to respond to trend information. The benefit is not simply the number of glucose readings but the ability to identify excursions and adjust insulin and nutrition in near real time. Implementation requires education, device access and rapid clinician feedback. The study supports a multidisciplinary model involving obstetrics, diabetology and diabetes educators, particularly for women at high risk of fetal overgrowth or glycemic instability.
4 weeks back

A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
2 days back

Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back

Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
3 days back

A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
3 days back

Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
3 days back